Aurinia Pharmaceuticals Inc
F:IKAP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aurinia Pharmaceuticals Inc
F:IKAP
|
CA |
|
Visual Processing Japan Co Ltd
TSE:334A
|
JP |
Wall St Price Targets
IKAP Price Targets Summary
Aurinia Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for IKAP is 10.37 EUR with a low forecast of 9.06 EUR and a high forecast of 13.187 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IKAP's stock price target?
Price Target
10.37
EUR
According to Wall Street analysts, the average 1-year price target for IKAP is 10.37 EUR with a low forecast of 9.06 EUR and a high forecast of 13.187 EUR.
What is the Revenue forecast for Aurinia Pharmaceuticals Inc?
Projected CAGR
14%
Over the last 14 years, the compound annual growth rate for Revenue has been 50%. The projected CAGR for the next 8 years is 14%.
What is the Operating Income forecast for Aurinia Pharmaceuticals Inc?
Projected CAGR
22%
The compound annual growth rate for Operating Income over the next 8 years is 22%.
What is the Net Income forecast for Aurinia Pharmaceuticals Inc?
Projected CAGR
1%
The compound annual growth rate for Net Income over the next 8 years is 1%.
